UK markets close in 3 hours 35 minutes
  • FTSE 100

    7,560.99
    +51.84 (+0.69%)
     
  • FTSE 250

    20,406.01
    +23.25 (+0.11%)
     
  • AIM

    933.06
    -1.05 (-0.11%)
     
  • GBP/EUR

    1.1869
    +0.0010 (+0.08%)
     
  • GBP/USD

    1.2022
    -0.0037 (-0.30%)
     
  • BTC-GBP

    20,011.89
    -130.27 (-0.65%)
     
  • CMC Crypto 200

    573.11
    -17.66 (-2.99%)
     
  • S&P 500

    4,297.14
    +16.99 (+0.40%)
     
  • DOW

    33,912.44
    +151.39 (+0.45%)
     
  • CRUDE OIL

    90.27
    +0.86 (+0.96%)
     
  • GOLD FUTURES

    1,790.40
    -7.70 (-0.43%)
     
  • NIKKEI 225

    28,868.91
    -2.87 (-0.01%)
     
  • HANG SENG

    19,830.52
    -210.34 (-1.05%)
     
  • DAX

    13,900.14
    +83.53 (+0.60%)
     
  • CAC 40

    6,599.93
    +29.98 (+0.46%)
     

Amphenol Reports First Quarter 2022 Results

  • Oops!
    Something went wrong.
    Please try again later.
·17-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

First Quarter 2022 Highlights:

  • Sales of $2.952 billion, up 24% in U.S. dollars and 17% organically compared to the first quarter 2021

  • GAAP diluted EPS of $0.68, up 28% compared to prior year

  • Adjusted Diluted EPS of $0.67, up 29% compared to prior year

  • Operating Margin of 20.0%

  • Operating Cash Flow and Free Cash Flow of $351 million and $274 million

  • Returned more than $320 million to shareholders through dividends and buybacks

WALLINGFORD, Conn., April 27, 2022--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) today reported first quarter 2022 results.

"We are pleased to have closed the first quarter of 2022 with sales and Adjusted Diluted EPS exceeding the high end of our guidance," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "Sales increased from prior year by a strong 24%, supported by robust growth across all of our end markets, as well as contributions from the Company’s acquisition program. Despite facing substantial inflationary pressures and supply chain disruptions, we realized strong profitability, with operating margins reaching 20.0% and Adjusted Diluted EPS growing by an impressive 29% from prior year. We are very proud of the Company’s outstanding performance in this most challenging and dynamic quarter."

New Segment Reporting

As previously announced, beginning this quarter, the Company is reporting its financial results in three new segments: Harsh Environment Solutions (HES), Communications Solutions (CS) and Interconnect and Sensor Systems (ISS). The accompanying financial data reflects these new segments, as well as the recasting of relevant prior year period segment information in order to enable year-over-year segment comparisons.

Second Quarter 2022 Outlook

The current market environment remains highly uncertain, with continued supply chain and inflationary challenges as well as ongoing disruptions associated with the COVID-19 pandemic. Assuming conditions do not meaningfully worsen and assuming constant exchange rates, for the second quarter of 2022, Amphenol expects sales to be in the range of $2.890 billion to $2.950 billion, representing 9% to 11% growth over the second quarter of 2021. Adjusted Diluted EPS is expected to be in the range of $0.66 to $0.68, representing 8% to 11% growth over the second quarter of 2021.

"Despite the ongoing challenges and uncertainties around the world, we are very pleased with the Company’s strong First Quarter results," Mr. Norwitt continued. "The revolution in electronics continues to accelerate, creating exciting and dynamic long-term growth opportunities for Amphenol across each of our diversified end markets. Our ongoing drive to leverage our competitive advantages and create sustained financial strength, as well as our initiatives to expand our product offerings, both organically and through our acquisition program, have created an excellent base for the Company’s future performance. I am confident in the ability of our outstanding entrepreneurial management team to continue to dynamically adjust to changing market conditions, to capitalize on the wide array of growth opportunities that arise in all market cycles and to continue to generate sustainable long-term value for our shareholders and other stakeholders. Most importantly, I remain truly grateful to our team for their extraordinary efforts in navigating the myriad of challenges around the world and continuing to strongly support our customers and drive outstanding operating performance."

Conference Call and Webcast Details

The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT) on Wednesday, April 27, 2022. The toll-free dial-in number is 888-455-0949; International dial-in number is +1-773-799-3973; Passcode: LAMPO. A replay of the call will be available until 11:59 PM (EDT) on Friday, May 27, 2022. The replay numbers are toll free 888-282-0036; International toll number +1-203-369-3022; Passcode: 7183.

A live broadcast as well as a replay of the call can be accessed through the Investor Relations section of the company’s website at https://investors.amphenol.com.

About Amphenol

Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in the Americas, Europe, Asia, Australia and Africa and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Broadband Communications, Commercial Aerospace, Industrial, Information Technology and Data Communications, Military, Mobile Devices and Mobile Networks. For more information, visit www.amphenol.com.

Non-GAAP Financial Measures

The financial statements included within this press release are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP" or "U.S. GAAP"). This press release also contains certain non-GAAP financial measures, including Adjusted Operating Income, Adjusted Operating Margin, Adjusted Net Income attributable to Amphenol Corporation, Adjusted Effective Tax Rate, Adjusted Diluted EPS, Organic Sales Growth, and Free Cash Flow (collectively, "non-GAAP financial measures"), which are intended to supplement the reported GAAP results. Management utilizes these non-GAAP financial measures as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company’s financial performance, communicating operating results to the Company’s Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company’s overall financial performance, trends and period-over-period comparative results, in addition to the reasons noted later within this press release. Non-GAAP financial measures related to operating income, operating margin, net income attributable to Amphenol Corporation, effective tax rate and diluted EPS exclude income and expenses that are not directly related to the Company’s operating performance during the periods presented. Items excluded in the presentation of these non-GAAP financial measures in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs, and certain discrete tax items including but not limited to (i) the excess tax benefits related to stock-based compensation and (ii) the impact of significant changes in tax law. Non-GAAP financial measures related to net sales exclude the impact related to foreign currency exchange and acquisitions. Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures are included at the end of this press release. However, such non-GAAP financial measures should not be considered in isolation, as a substitute for or superior to the related U.S. GAAP financial measures. In addition, these non-GAAP financial measures are not necessarily the same or comparable to similar measures presented by other companies as such measures may be calculated differently or may exclude different items. The non-GAAP financial measures are defined within the "Supplemental Financial Information" table at the end of this press release and should be read in conjunction with the Company’s financial statements presented in accordance with U.S. GAAP.

Forward-Looking Statements

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based on our management’s assumptions and beliefs about future events or circumstances using information currently available, and as a result, they are subject to risks and uncertainties. Forward-looking statements address events or developments that Amphenol Corporation expects or believes may or will occur in the future. These forward-looking statements, which address the Company’s expected business and financial performance and financial condition, among other matters, may contain words and terms such as: "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "guidance," "intend," "look ahead," "may," "ongoing," "optimistic," "plan," "potential," "predict," "project," "seek," "should," "target," "will" or "would" and other words and terms of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about expected earnings, revenues, growth, liquidity, effective tax rate or other matters, together with any forward-looking statements related in any way to the COVID-19 pandemic, including its future impact on the Company. Although the Company believes the expectations reflected in all forward-looking statements, including those we may make regarding second quarter 2022 sales and Adjusted Diluted EPS, among other matters, are based upon reasonable assumptions, the expectations may not be attained or there may be material deviation. Readers and investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

There are risks and uncertainties that could cause actual results to differ materially from these forward-looking statements, which include, but are not limited to, the following: political, economic, military and other risks related to operating in countries outside the United States, as well as changes in general economic conditions, geopolitical conditions, U.S. trade policies (including but not limited to sanctions) and other factors beyond the Company’s control; future risks and existing uncertainties associated with adverse public health developments, including epidemics and pandemics such as the COVID-19 pandemic, which continues to disrupt our operations including government regulations that inhibit our ability to operate certain of our facilities in the ordinary course, travel restrictions, supplier constraints, supply chain interruptions, logistics challenges and limitations, labor disruptions and reduced demand from certain customers; uncertainties associated with a protracted economic slowdown that could negatively affect the financial condition of our customers; risks associated with our inability to obtain certain raw materials and components in the current challenging supply chain environment, as well as the risk that the cost of most of the Company’s raw materials and components is increasing; negative impacts caused by extreme weather conditions and natural catastrophic events, including those caused by climate change and global warming; risks associated with the improper conduct by any of our employees, customers, suppliers, distributors or any other business partners which could impair our business reputation and financial results and could result in our non-compliance with anti-corruption laws and regulations of the U.S. government and various foreign jurisdictions; changes in exchange rates of the various currencies in which the Company conducts business; the risks associated with the Company’s dependence on attracting, recruiting, hiring and retaining skilled employees, including as part of our various management teams; the Company’s dependence on sales to the communications industry, which markets are dominated by large manufacturers and operators who regularly exert significant pressure on suppliers, including the Company; changes in defense expenditures in the military market, including the impact of reductions or changes in the defense budgets of U.S. and foreign governments; risks and difficulties in trying to compete successfully on the basis of technology innovation, product quality and performance, price, customer service and delivery time; difficulties and unanticipated expenses in connection with purchasing and integrating newly acquired businesses, including the potential for the impairment of goodwill and other intangible assets; events beyond the Company’s control that could lead to an inability to meet its financial and other covenants, which could result in a default under the Company’s revolving credit facility or unsecured term loan credit facility; risks associated with the Company’s inability to access the global capital markets on favorable terms, including as a result of significant deterioration of general economic or capital market conditions, or as a result of a downgrade in the Company’s credit rating; changes in interest rates; cybersecurity threats, including but not limited to malware, phishing, credential harvesting, ransomware and other increasingly sophisticated attacks, that could impair our information technology systems and could disrupt business operations, result in the loss of or inability to access confidential information and critical business, financial or other data, and/or cause the release of highly sensitive confidential information, any of which could adversely impact our reputation and operating results and potentially lead to litigation and/or governmental investigations and fines; government contracting risks that the Company may be subject to, including laws and regulations governing performance of government contracts and related risks associated with conducting business with the U.S. and other foreign governments or their suppliers (both directly and indirectly); governmental export and import controls that certain of our products may be subject to, including export licensing, customs regulations, economic sanctions and other laws; changes in fiscal and tax policies, audits and examinations by taxing authorities, laws, regulations and guidance in the United States and foreign jurisdictions; any difficulties in protecting the Company’s intellectual property rights; litigation, customer claims, product recalls, governmental investigations, criminal liability or environmental matters including changes to laws and regulations to which the Company may be subject; and incremental costs and other risks that may arise in connection with regulatory efforts to combat the negative effects of climate change. In addition, the extent to which the COVID-19 pandemic will continue to impact our business and financial results going forward will be dependent on future developments such as the length and severity of the crisis, the impact of any additional resurgences from known or new variants, current and future government regulations and actions in response to the crisis, the timing, availability, effectiveness and adoption rates of vaccines and treatments, and the overall impact of the COVID-19 pandemic on the global economy and capital markets, among many other factors, all of which remain highly uncertain and unpredictable.

A further description of these uncertainties and other risks can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, Quarterly Reports on Form 10-Q and the Company’s other reports filed with the Securities and Exchange Commission. These or other uncertainties may cause the Company’s actual future results to be materially different from those expressed in any forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(dollars and shares in millions, except per share data)

Three Months Ended

March 31,

2022

2021

Net sales

$

2,951.9

$

2,377.1

Cost of sales

2,025.3

1,649.6

Gross profit

926.6

727.5

Selling, general and administrative expenses

336.8

262.7

Operating income

589.8

464.8

Interest expense

(28.1

)

(28.6

)

Other income (expense), net

1.7

(0.3

)

Income before income taxes

563.4

435.9

Provision for income taxes (1)

(134.2

)

(104.1

)

Net income

429.2

331.8

Less: Net income attributable to noncontrolling interests

(3.5

)

(2.2

)

Net income attributable to Amphenol Corporation

$

425.7

$

329.6

Net income attributable to Amphenol Corporation per common share — Basic

$

0.71

$

0.55

Weighted average common shares outstanding — Basic

598.3

598.5

Net income attributable to Amphenol Corporation per common share — Diluted (2)

$

0.68

$

0.53

Weighted average common shares outstanding — Diluted

625.6

624.1

_______________________________

Note 1

Provision for income taxes for the three months ended March 31, 2022 and 2021 includes excess tax benefits related to stock-based compensation of

$3.8 million ($0.01 per share) and $2.6 million ($0.00 per share), respectively.

Note 2

Net income per share for the three months ended March 31, 2022 and 2021 includes the excess tax benefits related to stock-based compensation

discussed in Note 1.

Excluding these effects and the impact of rounding, Adjusted Diluted EPS, a non-GAAP financial measure which is defined and reconciled to its

most comparable GAAP financial measure in this press release, was $0.67 and $0.52 for the three months ended March 31, 2022 and 2021, respectively.

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(dollars in millions)

March 31,

December 31,

2022

2021

ASSETS

Current Assets:

Cash and cash equivalents

$

1,247.5

$

1,197.1

Short-term investments

52.1

44.3

Total cash, cash equivalents and short-term investments

1,299.6

1,241.4

Accounts receivable, less allowance for doubtful accounts of $47.2 and $43.5, respectively

2,422.1

2,454.8

Inventories

1,989.7

1,894.1

Prepaid expenses and other current assets

397.3

367.9

Total current assets

6,108.7

5,958.2

Property, plant and equipment, less accumulated depreciation of $2,007.3 and $1,961.6, respectively

1,175.0

1,175.3

Goodwill

6,349.1

6,376.8

Other intangible assets, net

738.4

756.9

Other long-term assets

502.4

411.2

Total Assets

$

14,873.6

$

14,678.4

LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND EQUITY

Current Liabilities:

Accounts payable

$

1,275.9

$

1,312.0

Accrued salaries, wages and employee benefits

272.3

366.2

Accrued income taxes

116.6

88.8

Accrued dividends

119.5

119.8

Other accrued expenses

589.2

556.3

Current portion of long-term debt

23.7

4.0

Total current liabilities

2,397.2

2,447.1

Long-term debt, less current portion

4,908.8

4,795.9

Accrued pension and postretirement benefit obligations

187.8

193.4

Deferred income taxes

421.7

424.2

Other long-term liabilities

454.6

438.7

Total Liabilities

8,370.1

8,299.3

Redeemable noncontrolling interest

19.5

19.0

Equity:

Common stock

0.6

0.6

Additional paid-in capital

2,438.5

2,409.0

Retained earnings

4,391.5

4,278.9

Treasury stock, at cost

(101.0

)

(100.0

)

Accumulated other comprehensive loss

(303.5

)

(286.5

)

Total stockholders’ equity attributable to Amphenol Corporation

6,426.1

6,302.0

Noncontrolling interests

57.9

58.1

Total Equity

6,484.0

6,360.1

Total Liabilities, Redeemable Noncontrolling Interest and Equity

$

14,873.6

$

14,678.4

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

(dollars in millions)

Three Months Ended

March 31,

2022

2021

Cash from operating activities:

Net income

$

429.2

$

331.8

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

91.1

76.7

Stock-based compensation expense

19.7

19.1

Deferred income tax provision

13.4

14.2

Net change in components of working capital

(182.9

)

(114.6

)

Net change in other long-term assets and liabilities

(19.7

)

(6.2

)

Net cash provided by operating activities

350.8

321.0

Cash from investing activities:

Capital expenditures

(78.1

)

(78.4

)

Proceeds from disposals of property, plant and equipment

1.8

0.9

Purchases of investments

(100.3

)

(46.2

)

Sales and maturities of investments

35.8

48.5

Acquisitions, net of cash acquired

(185.6

)

Other

(3.3

)

(2.4

)

Net cash used in investing activities

(144.1

)

(263.2

)

Cash from financing activities:

Proceeds from issuance of senior notes and other long-term debt

0.2

1.2

Repayments of senior notes and other long-term debt

(2.5

)

(0.8

)

Proceeds from short-term borrowings

20.1

Borrowings (repayments) under commercial paper programs, net

138.4

811.9

Purchase of treasury stock

(204.0

)

(152.8

)

Proceeds from exercise of stock options

20.0

21.1

Distributions to and purchases of noncontrolling interests

(3.6

)

(7.6

)

Dividend payments

(119.8

)

(86.8

)

Net cash (used in) provided by financing activities

(151.2

)

586.2

Effect of exchange rate changes on cash and cash equivalents

(5.1

)

(18.4

)

Net increase in cash and cash equivalents

50.4

625.6

Cash and cash equivalents balance, beginning of period

1,197.1

1,702.0

Cash and cash equivalents balance, end of period

$

1,247.5

$

2,327.6

Cash paid for:

Interest

$

27.6

$

28.1

Income taxes, net

93.8

75.2

AMPHENOL CORPORATION

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting